$
2. 08
-0.15
-6.9507%
After Hours
$
+0.07 +3.6145% 2. 15
8.55M Market Cap
- P/E Ratio
- Div Yield
214,804 Volume
-2.28 Eps
$ 2.23
Previous Close Investors:
Want to track NXTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NextCure, Inc. (NXTC) Statistics
Valuation metrics
Market Cap 8.55M
Enterprise value -3.38M
Trailing P/E (ttm) -0.28
Forward P/E -1.17
PEG ratio -0.1
Price/Sales (ttm) -
Price/Book (mrq) 0.58
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.06
Overview
Shares outstanding 3.51M
Float 2.28M
Shares short 72.14K
% Held by insiders 0.15%
% Held by institutions 0.56%
Average volume (10 days) 105.54K
Average volume (90 days) 51.15K
Price summary
52-Week low 2
52-Week high 15.74
Beta 1.58
50-Day moving average 9.59
200-Day moving average 11.54
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:12
Last split Date 14 Jul 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.44%
Return on equity -1.87%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -54.28M
Net income to common (ttm) -54.66M
Diluted EPS (ttm) -10.43
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 29.74M
Total cash per share (mrq) 5.68
Total debt (mrq) 3.88M
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 4.61%
Book value per share (mrq) 5.1
Cash Flow
Cash flow statement -49.98M
Levered free cash flow (LFCF) -27.14M
